“We are thrilled to have clarity from FDA on the safety database recommendations following submission of safety information included in a briefing package from our nomlabofusp program.

After the CVE’s program’s near-death experience in April, might the Europeans be looking for a more reliable long-term system? From this week, the global technology industry has a new database ...